HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
25 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NOX4
NADPH oxidase 4
Chromosome 11 · 11q14.3
NCBI Gene: 50507Ensembl: ENSG00000086991.13HGNC: HGNC:7891UniProt: B3KQ17
396PubMed Papers
20Diseases
1Drugs
0Pathogenic Variants
RESEARCH IMPACT
Highly StudiedTrending
CLINICAL
Clinical Trials
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
superoxide metabolic processprotein bindingsuperoxide-generating NAD(P)H oxidase activityperinuclear region of cytoplasmhair coloraneurysmcancerAlzheimer disease
✦AI Summary

NOX4 (NADPH oxidase 4) is a constitutively active enzyme that generates hydrogen peroxide (H2O2) rather than superoxide as its primary reactive oxygen species product 1. Unlike other NOX family members, NOX4 functions as a key oxygen sensor through its unique structural properties that enable continuous H2O2 production 1. The enzyme plays critical roles in cellular processes including proliferation, migration, and cell death through oxidative signaling 1. NOX4 exhibits tissue-specific functions with both protective and pathogenic roles depending on cellular context. In hepatocytes, NOX4 provides cytoprotective antioxidant defense by activating NFE2L2 (Nrf2) signaling, preventing progression from fatty liver to steatohepatitis and fibrosis 2. However, NOX4 also promotes pathological processes including cancer progression through enhancement of angiogenesis, metastasis, and drug resistance mechanisms 13. In cancer-associated fibroblasts, NOX4 maintains immunosuppressive phenotypes that exclude CD8+ T cells from tumors 4. The enzyme contributes to neurodegeneration by promoting ferroptosis in astrocytes through oxidative stress-induced lipid peroxidation and mitochondrial dysfunction 5. NOX4 also participates in cardiac hypertrophy and renal fibrosis pathogenesis 67. Given its diverse pathological roles, NOX4 represents a promising therapeutic target, with inhibitors showing efficacy in preclinical models of cancer, fibrosis, and cardiovascular disease.

Sources cited
1
NOX4 constitutively generates H2O2 as main product and functions as oxygen sensor in cell proliferation, migration and death
PMID: 25950600
2
NOX4 provides cytoprotective antioxidant defense in hepatocytes by activating NFE2L2 signaling to prevent NASH progression
PMID: 38060313
3
NOX4 in cancer-associated fibroblasts maintains immunosuppressive phenotype and excludes CD8+ T cells from tumors
PMID: 32122909
4
NOX4 promotes EGFR-TKI resistance in NSCLC through IL-8/PD-L1 signaling pathway
PMID: 37392558
5
NOX4 promotes ferroptosis of astrocytes through oxidative stress-induced lipid peroxidation and mitochondrial dysfunction in Alzheimer's disease
PMID: 33774476
6
NOX4 contributes to cardiac hypertrophy pathogenesis and represents therapeutic target
PMID: 37795828
7
NOX4 is involved in renal fibrosis through ferroptosis pathway activation
PMID: 38844470
Disease Associationsⓘ20
hair colorOpen Targets
0.51Moderate
aneurysmOpen Targets
0.45Moderate
cancerOpen Targets
0.40Weak
Alzheimer diseaseOpen Targets
0.38Weak
acute myeloid leukemiaOpen Targets
0.38Weak
Abdominal Aortic AneurysmOpen Targets
0.35Weak
glaucomaOpen Targets
0.35Weak
cervical carcinomaOpen Targets
0.31Weak
deficiency anemiaOpen Targets
0.31Weak
protozoa infectious diseaseOpen Targets
0.30Weak
diabetic retinopathyOpen Targets
0.27Weak
crush injuryOpen Targets
0.27Weak
Genu valgumOpen Targets
0.26Weak
Genu varumOpen Targets
0.26Weak
placenta praeviaOpen Targets
0.26Weak
hypertrophic cardiomyopathyOpen Targets
0.25Weak
adolescent idiopathic scoliosisOpen Targets
0.25Weak
attention deficit hyperactivity disorderOpen Targets
0.19Weak
benign chondrogenic neoplasmOpen Targets
0.19Weak
major depressive disorderOpen Targets
0.18Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets1
SETANAXIBPhase II
NADPH oxidase 1 inhibitor
fibrosis
Related Genes
POLDIP2Protein interaction100%NOXO1Protein interaction100%TLR4Protein interaction100%CYBAProtein interaction99%NCF2Protein interaction99%NCF4Protein interaction99%
Tissue Expression6 tissues
Heart
100%
Lung
31%
Brain
21%
Ovary
18%
Liver
3%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
NOX4POLDIP2NOXO1TLR4CYBANCF2NCF4
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q9NPH5
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.02LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.74 [0.54–1.02]
RankingsWhere NOX4 stands among ~20K protein-coding genes
  • #746of 20,598
    Most Researched396 · top 5%
  • #9,959of 17,882
    Most Constrained (LOEUF)1.02
Genes detectedNOX4
Sources retrieved25 papers
Response time—
📄 Sources
25▼
1
NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors.
PMID: 32122909
Cancer Res · 2020
1.00
2
HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.
PMID: 38844470
Cell Death Dis · 2024
0.90
3
Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity.
PMID: 38060313
J Clin Invest · 2023
0.80
4
Neutrophil membrane-engineered Panax ginseng root-derived exosomes loaded miRNA 182-5p targets NOX4/Drp-1/NLRP3 signal pathway to alleviate acute lung injury in sepsis: experimental studies.
PMID: 37737899
Int J Surg · 2024
0.76
5
Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
PMID: 37061215
J Adv Res · 2024
0.70